BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 25641795)

  • 1. Biodegradable nanoellipsoidal artificial antigen presenting cells for antigen specific T-cell activation.
    Meyer RA; Sunshine JC; Perica K; Kosmides AK; Aje K; Schneck JP; Green JJ
    Small; 2015 Apr; 11(13):1519-25. PubMed ID: 25641795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shape matters: Biodegradable anisotropic nanoparticle artificial antigen presenting cells for cancer immunotherapy.
    Ben-Akiva E; Hickey JW; Meyer RA; Isser A; Shannon SR; Livingston NK; Rhodes KR; Kosmides AK; Warren TR; Tzeng SY; Schneck JP; Green JJ
    Acta Biomater; 2023 Apr; 160():187-197. PubMed ID: 36812956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Size-transformable antigen-presenting cell-mimicking nanovesicles potentiate effective cancer immunotherapy.
    Yang W; Deng H; Zhu S; Lau J; Tian R; Wang S; Zhou Z; Yu G; Rao L; He L; Ma Y; Chen X
    Sci Adv; 2020 Dec; 6(50):. PubMed ID: 33310853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEGylated and CD47-conjugated nanoellipsoidal artificial antigen-presenting cells minimize phagocytosis and augment anti-tumor T-cell responses.
    Song S; Jin X; Zhang L; Zhao C; Ding Y; Ang Q; Khaidav O; Shen C
    Int J Nanomedicine; 2019; 14():2465-2483. PubMed ID: 31040669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells.
    Sunshine JC; Perica K; Schneck JP; Green JJ
    Biomaterials; 2014 Jan; 35(1):269-277. PubMed ID: 24099710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation.
    Ben-Akiva E; Rhodes KR; Meyer RA; Green JJ
    J Vis Exp; 2018 Oct; (140):. PubMed ID: 30371668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell activation by processed antigen is equally blocked by I-E and I-A-restricted immunodominant peptides.
    Lakey EK; Casten LA; Anderson MS; Smolenski LA; Smith JA; Margoliash E; Pierce SK
    Eur J Immunol; 1987 Nov; 17(11):1605-9. PubMed ID: 3500065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phylogenetic hierarchy of antigen-presenting ability in antigen-specific T cell activation.
    Yano A; Yui K; Yamashita K; Aosai F; Okumura N; Yabu K
    Immunol Lett; 1985; 11(1):9-13. PubMed ID: 3876988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometry used for the analysis of calcium signaling induced by antigen-specific T-cell activation.
    Réthi B; Detre C; Gogolák P; Kolonics A; Magócsi M; Rajnavölgyi E
    Cytometry; 2002 Apr; 47(4):207-16. PubMed ID: 11933010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nature and role of antigen processing in T-cell activation.
    Berzofsky JA
    Year Immunol; 1985; ():18-24. PubMed ID: 3916381
    [No Abstract]   [Full Text] [Related]  

  • 11. Autologous designer antigen-presenting cells by gene modification of T lymphocyte blasts with IL-7 and IL-12.
    Foster AE; Leen AM; Lee T; Okamura T; Lu A; Vera J; Atkinson R; Bollard CM; Dotti G; Rooney CM
    J Immunother; 2007; 30(5):506-16. PubMed ID: 17589291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and cellular aspects of T-lymphocyte responses to antigen.
    Segall M
    Transfusion; 1991 Feb; 31(2):180-7. PubMed ID: 1899952
    [No Abstract]   [Full Text] [Related]  

  • 13. Antigen presentation by cells that are not of bone marrow origin.
    Geppert TD; Lipsky PE
    Reg Immunol; 1989; 2(1):60-71. PubMed ID: 2518360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two roles for Ia in antigen-specific T cell activation. II. Toward a Velcro model of antigen recognition.
    Kim KH; Thomas DW
    J Immunol; 1988 Apr; 140(8):2500-7. PubMed ID: 3258611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the relative roles of antigen and nonantigen signals in activation of allogeneic T cells.
    Uren S; Boyle W
    Transplant Proc; 1989 Oct; 21(5):3753-4. PubMed ID: 2530673
    [No Abstract]   [Full Text] [Related]  

  • 16. Antigen-specific and -nonspecific mitogenic signals in the activation of human T cell clones.
    Nisbet-Brown ER; Lee JW; Cheung RK; Gelfand EW
    J Immunol; 1987 Jun; 138(11):3713-9. PubMed ID: 2953789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of T lymphocyte reactivity to complex antigen mixtures by the use of proteins coupled to latex beads.
    Wirbelauer C; Meding S; Stockinger B; Gillard S; Langhorne J
    Immunol Lett; 1990 Feb; 23(4):257-62. PubMed ID: 2189827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two roles for Ia in antigen-specific T lymphocyte activation.
    Kim KH; Shivdasani RA; Thomas DW
    J Immunol; 1986 Dec; 137(11):3393-400. PubMed ID: 3491135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen presentation by human antigen-presenting cells to antigen-specific xenogeneic murine T cells.
    Yabu K; Yano A
    Microbiol Immunol; 1986; 30(3):237-48. PubMed ID: 3487694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular requirements for antigen processing by antigen-presenting cells: evidence for different pathways in forming the same antigenic determinants.
    Kim KH; Solvay MJ; Thomas DW
    Cell Immunol; 1985 Dec; 96(2):267-76. PubMed ID: 3879804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.